Latest filings (excl ownership)
CT ORDER
Confidential treatment order
5 Jan 10
10-K
2009 FY
Annual report
28 Oct 09
8-K
Raptor Pharmaceuticals and TorreyPines Therapeutics Receive
6 Oct 09
EFFECT
Notice of effectiveness
1 Oct 09
15-12G
Securities registration termination
30 Sep 09
POS AM
Prospectus update (post-effective amendment)
30 Sep 09
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Sep 09
D
$2.39M in equity / options, sold $2.39M, 4 investors
16 Sep 09
425
Business combination disclosure
31 Aug 09
8-K
2009 Annual Meeting of Stockholders
31 Aug 09
DEF 14A
Definitive proxy
31 Aug 09
425
Business combination disclosure
25 Aug 09
425
Business combination disclosure
25 Aug 09
8-K
Entry into a Material Definitive Agreement
25 Aug 09
424B3
Prospectus supplement
31 Jul 09
8-K
Entry into a Material Definitive Agreement
31 Jul 09
8-K
Entry into a Material Definitive Agreement
28 Jul 09
8-K
Regulation FD Disclosure
24 Jul 09
424B3
Prospectus supplement
23 Jul 09
10-Q
2009 Q3
Quarterly report
15 Jul 09
424B3
Prospectus supplement
23 Jun 09
8-K
Regulation FD Disclosure
23 Jun 09
8-K
Entry into a Material Definitive Agreement
9 Jun 09
8-K
Other Events
1 May 09
UPLOAD
Letter from SEC
27 Apr 09
10-K/A
2008 FY
Annual report (amended)
20 Apr 09
8-K
Entry into a Material Definitive Agreement
14 Apr 09
10-Q
2009 Q2
Quarterly report
13 Apr 09
424B3
Prospectus supplement
13 Apr 09
CORRESP
Correspondence with SEC
9 Apr 09
CORRESP
Correspondence with SEC
25 Mar 09
UPLOAD
Letter from SEC
13 Mar 09
424B3
Prospectus supplement
14 Jan 09
10-Q
2009 Q1
Quarterly report
13 Jan 09
424B3
Prospectus supplement
13 Jan 09
8-K
Entry into a Material Definitive Agreement
5 Jan 09
10-K/A
2008 FY
Annual report (amended)
23 Dec 08
424B3
Prospectus supplement
12 Dec 08
Latest ownership filings
No filings